Human papillomavirus testing as an adjunct to cytology evaluation in cervical specimens of selected and consecutively screened Lebanese women: A prospective clinical study

Journal Medical Libanais

Volumn 53, Issue 3, 2005, Pages 132-138

  Karam, Walid G ^a   Bedran, Farid ^b   Tohme, Rania A ^c   Moukarbel, Nada ^a   Abdallah, Inaya ^c   Jurjus, Abdo R ^c   Jurjus, Rosy A ^c   Khairallah, Saad ^a   Aftimos, Georges ^a  

^a Institut National de Pathologie   (Lebanon)

^b Serhal Hospital   (Lebanon)

^c AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER SCREENING; CONTROLLED STUDY; CYTOLOGY; DISEASE ASSOCIATION; DNA DETERMINATION; FEMALE; GYNECOLOGIC DISEASE; HIGH RISK POPULATION; HUMAN; LEBANON; LIFESTYLE; MAJOR CLINICAL STUDY; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VIRUS IDENTIFICATION; VIRUS INFECTION; WART VIRUS;

EID: 33745111802     PISSN: 00239852     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Parkin DM, Pisani P, Ferlay J. Global Cancer Statistics. CA Cancer J Clin 1999; 49: 33-64.
2. Wright TC, Schiffman M, Solomon D et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol 2004; 103: 304-9.
3. Lorenzato M, Bory JP, Cucherousset J et al. Usefulness of DNA ploidy measurement on liquid based smears showing conflicting results between cytology and high-risk human papillomavirus typing. Am J Clin Path 2002; 118: 708-13.
4. Munoz N, Bosch X, De Sanjose S et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-27.
5. Xi LF, Touré P, Critchlow CW et al. Prevalence of specific types of human papillomavirus and cervical squamous intraepithelial lesions in consecutive, previously unscreened, West-African women over 35 years of age. Int J Cancer 2003; 103: 803-9.
6. Lazcano-Ponce E, Herrero R, Munoz N et al. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer 2001; 91: 412-20.
7. Schiffman M, Herrero R, Hildesheim A et al. HPV DNA testing in cervical cancer screening: Results from women in a high-risk province of Costa-Rica. JAMA 2000; 283: 87-93.
8. Bosch FX, Manos MM, Munoz N et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) study group. J Natl Cancer Inst 1995; 87: 796.
9. Mroueh AM, Seoud MAF, Kaspar HG, Zalloua PA. Prevalence of genital human papillomavirus among Lebanese women. Eur J Gynaecol Oncol 2002; 13: 429-32.
10. Cuzick J, Beverly E, Ho L et al. HPV testing in primary screening of older women. Br J Cancer 1999; 81: 554-8.
11. De Rada Husman AM, Walboomers JM, Hopman E et al. HPV prevalence in cytomorphologically normal scrapes of pregnant women as determined by PCR: the age-related pattern. J Med Virol 1995; 46: 97-102.
12. Herrero R, Hildesheim A, Bratti C et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 2000; 92: 464-74.
13. Ho G, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998; 338: 423-8.
14. Melkert PW, Hopman E, Van den Brule AJ et al. Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the Polymerase Chain Reaction, is age-dependent. Int J Cancer 1993; 53: 919-23.
15. Hinchliffe SA, Van Velzen D, Korporaal H, Kok PL, Boon ME. Transience of cervical HPV infection in sexually active young women with normal cervicovaginal cytology. Br J Cancer 1995; 72: 943-5.
16. Shen LH, Rushing L, Mclachlin CN, Sheets EE, Crum CT. Prevalence and histologic significance of cervical human papillomavirus detected in women at low and high risk for cervical neoplasia. Obstet Gynecol 1995; 86: 495-503.
17. Nanda K, McCrory DC, Myers ER et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med 2000; 132: 810-19.
18. Raab SS. Human papillomavirus reporting. Impact on Bethesda cytology reports. Arch Pathol Lab Med 2003; 127: 969-72.
19. Lorincz AT, Richart RM. Human papillomavirus DNA testing as an adjuvant to cytology in cervical screening programs. Arch Pathol Lab Med 2003; 127: 959-68.
20. Mandelblatt JS, Lawrence FW, Womack SM et al. Benefits and costs of using HPV testing to screen for cervical cancer. JAMA 2002; 287: 2372-81.
21. Mant C, Kell B, Best JM, Cason J. Polymerase chain reaction protocols for the detection of DNA from mucosal human papillomavirus types 6, 11, 16, 18, 31 and 33. J Virol Methods 1997; 66: 169-78.
22. Fuginaga Y, Shimada M, Okasawa K, Fukushima M, Kato I, Fujinaga K. Simultaneous detection and typing of genital human papillomavirus DNA using polymerase chain reaction. J Gen Virol 1991; 72: 1039-44.
23. Martinson JJ, Chapman NH, Ress DC et al. Global distribution of the CCR5 gene 32basepair deletion. Nature Genetics 1997; 16: 100-3.
24. Ley C, Bauer HM, Reingold A et al. Determinants of genital human papillomavirus infection in young women. J Natl Cancer Inst 1991; 83: 997-1003.
25. Cope JU, Hildesheim A, Sciffman MK et al. Comparison of the hybrid capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens. J Clin Microbiol 1997; 35: 2262-5.
26. Ekalaksananan T, Pientong C, Kotimanusvanij D et al. The relationship of human papillomavirus (HPV) detection to Pap smear classification of cervical-scraped cells in asymptomatic women in Northeast Thailand. Obstet Gynaecol Res 2001; 27: 117-24.
27. Kjaer SK, Van Der Brule AJ, Bock JE et al. Determinants of genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: are there, different risk profiles for oncogenic and nononcogenic HPV types? Cancer Epidemiol Biomarkers Prev 1997; 10: 799-805.
28. Franco EL, Villa LL, Sobrinho JP et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis 1999; 189: 1415-23.
29. Kochel HG, Teichmann A, Eckardt N et al. Occurrence of human papillomavirus DNA types 16 and 18 (HPV-16/18) in cervical smears as compared to cytological findings. Int J Gynaecol 1990; 31: 145-52.
30. Van Duin M, Snijders P JF, Henri FJ et al. Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II/III and viral clearance. Int J Cancer 2002; 98: 590-5.